Free Trial Information
BioCentury | Oct 19, 2018
Finance

Taiho ups its stakes

After bumping up its evergreen fund from $50 million to $300 million, Taiho Ventures LLC plans to increase its stakes in its portfolio companies. The strategic venture arm of Taiho Pharmaceutical Co. Ltd. launched in...
Read More
BioCentury | Oct 19, 2018
Financial News

Taiho Ventures increases investment pool to $300M

Taiho Ventures LLC increased its investment pool to $300 million from $50 million. The firm said it will focus the additional funds on oncology startups with drug discovery capabilities or unique platform technologies. Taiho Pharmaceutical...
Read More
BioCentury | Oct 16, 2018
Financial News

Taiho Ventures ups investments to $300M, to focus on oncology

Taiho Ventures LLC increased its investment pool to $300 million from $50 million. Taiho Ventures said it will focus the additional funds on oncology startups with drug discovery capabilities or unique platform technologies. Taiho Pharmaceutical...
Read More
BioCentury | May 23, 2016
Finance

Venturing west

After two years as an LP, Taiho Pharmaceutical Co. Ltd. is taking the plunge and creating its own strategic venture unit. The company isn't providing many details about its $50 million Taiho Ventures, but the...
Read More
BioCentury | Oct 14, 2013
Finance

Cornering Ventures West

...Cornering Ventures West After 40 years, Ventures West decided to close up shop this month rather than raise...
...to raise a healthcare-focused fund next year under the banner of Five Corners Capital . Ventures West...
...of eight funds, all from Canadian pension funds, endowments and institutional investors. The most recent, Ventures West...
Read More
BioCentury | Oct 7, 2013
Financial News

Five Corners Capital Inc. financial update

...Newly founded investment firm Five Corners Capital will assume management of the remaining portfolio of Ventures West...
...2007, and Gary Bridger, who was a venture partner at Ventures West in 2010-12. Galbraith said Ventures West...
...N.J.), infectious disease company Presidio Pharmaceuticals Inc. (San Francisco, Calif.) and MacroGenics Inc. (Rockville, Md.). Ventures West...
Read More
BioCentury | Oct 3, 2013
Financial News

Five Corners to manage portfolio of Ventures West

...Newly founded investment firm Five Corners Capital will assume management of the remaining portfolio of Ventures West...
...2007, and Gary Bridger, who was a venture partner at Ventures West in 2010-12. Galbraith said Ventures West...
...OTCBB:CLPM), infectious disease company Presidio Pharmaceuticals Inc. (San Francisco, Calif.) and MacroGenics Inc. (Rockville, Md.). Ventures West...
Read More
BioCentury | Apr 8, 2013
Finance

PI3K party

...led the series C round with participation from other existing investors, including Pfizer Venture Investments; Ventures West...
Read More
BioCentury | Apr 8, 2013
Financial News

Aquinox completes venture financing

...financing Raised: $18 million Investors: Johnson & Johnson Development Corp.; Augment Investments; Pfizer Venture Investments; Ventures West...
Read More
BioCentury | Apr 3, 2013
Financial News

Aquinox raises $18M in series C

...Development Corp. New investor Augment Investments also participated, along with existing investors Pfizer Venture Investments; Ventures West...
Read More
Items per page:
1 - 10 of 75
BioCentury | Oct 19, 2018
Finance

Taiho ups its stakes

After bumping up its evergreen fund from $50 million to $300 million, Taiho Ventures LLC plans to increase its stakes in its portfolio companies. The strategic venture arm of Taiho Pharmaceutical Co. Ltd. launched in...
Read More
BioCentury | Oct 19, 2018
Financial News

Taiho Ventures increases investment pool to $300M

Taiho Ventures LLC increased its investment pool to $300 million from $50 million. The firm said it will focus the additional funds on oncology startups with drug discovery capabilities or unique platform technologies. Taiho Pharmaceutical...
Read More
BioCentury | Oct 16, 2018
Financial News

Taiho Ventures ups investments to $300M, to focus on oncology

Taiho Ventures LLC increased its investment pool to $300 million from $50 million. Taiho Ventures said it will focus the additional funds on oncology startups with drug discovery capabilities or unique platform technologies. Taiho Pharmaceutical...
Read More
BioCentury | May 23, 2016
Finance

Venturing west

After two years as an LP, Taiho Pharmaceutical Co. Ltd. is taking the plunge and creating its own strategic venture unit. The company isn't providing many details about its $50 million Taiho Ventures, but the...
Read More
BioCentury | Oct 14, 2013
Finance

Cornering Ventures West

...Cornering Ventures West After 40 years, Ventures West decided to close up shop this month rather than raise...
...to raise a healthcare-focused fund next year under the banner of Five Corners Capital . Ventures West...
...of eight funds, all from Canadian pension funds, endowments and institutional investors. The most recent, Ventures West...
Read More
BioCentury | Oct 7, 2013
Financial News

Five Corners Capital Inc. financial update

...Newly founded investment firm Five Corners Capital will assume management of the remaining portfolio of Ventures West...
...2007, and Gary Bridger, who was a venture partner at Ventures West in 2010-12. Galbraith said Ventures West...
...N.J.), infectious disease company Presidio Pharmaceuticals Inc. (San Francisco, Calif.) and MacroGenics Inc. (Rockville, Md.). Ventures West...
Read More
BioCentury | Oct 3, 2013
Financial News

Five Corners to manage portfolio of Ventures West

...Newly founded investment firm Five Corners Capital will assume management of the remaining portfolio of Ventures West...
...2007, and Gary Bridger, who was a venture partner at Ventures West in 2010-12. Galbraith said Ventures West...
...OTCBB:CLPM), infectious disease company Presidio Pharmaceuticals Inc. (San Francisco, Calif.) and MacroGenics Inc. (Rockville, Md.). Ventures West...
Read More
BioCentury | Apr 8, 2013
Finance

PI3K party

...led the series C round with participation from other existing investors, including Pfizer Venture Investments; Ventures West...
Read More
BioCentury | Apr 8, 2013
Financial News

Aquinox completes venture financing

...financing Raised: $18 million Investors: Johnson & Johnson Development Corp.; Augment Investments; Pfizer Venture Investments; Ventures West...
Read More
BioCentury | Apr 3, 2013
Financial News

Aquinox raises $18M in series C

...Development Corp. New investor Augment Investments also participated, along with existing investors Pfizer Venture Investments; Ventures West...
Read More
Items per page:
1 - 10 of 75